Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Share Capital (Tables)

v3.22.1
Share Capital (Tables)
 12 Months Ended
Dec. 31, 2020
Share-Based Payment Arrangement [Abstract]  
Schedule of options granted outstanding and exercise prices
    Number of ordinary
shares		     Number of ordinary
shares		  
    Authorized     Issued and outstanding     Authorized     Issued and outstanding  
    December 31,
2020		     December 31,
2019		  
                                 
Ordinary shares     1,200,000,000       26,986,203       200,000,000       24,393,218  

 
Schedule of options granted outstanding and exercise prices
    Number of options     Weighted average exercise
price		    

Weighted average remaining contractual

life (years)

     Aggregate intrinsic-value  
                         
Outstanding as of January 1, 2020     1,814,381     $ 0.58                  
Granted     14,678,734       0.07                  
Options forfeited     (173,329 )   $ 0.74                  
                                 
Outstanding as of December 31, 2020     16,319,786     $ 0.12       5.79     $ 2,581,719  
                                 
Exercisable as of December 31, 2020     5,913,492     $ 0.14       5.40     $ 844,712  

 

    Number of options     Weighted average exercise
price		    

Weighted average remaining contractual

life (years)

     Aggregate intrinsic-value  
                         
Outstanding as of January 1, 2019     1,714,039     $ 0.63                  
Granted     207,500       0.27                  
Options forfeited     (107,158 )   $ 0.88                  
                                 
Outstanding as of December 31, 2019     1,814,381     $ 0.58       6.66     $ 24,538  
                                 
Exercisable as of December 31, 2019     1,209,464     $ 0.68       5.72     $ 24,538  

 
Schedule of options granted to officers, directors, employees, consultants and service providers
      Outstanding     Exercisable  
Exercise price     Number of
options		     Weighted average remaining contractual life (years)     Number of
options		     Weighted average remaining contractual life (years)  
                           
 
(*
 )     230,425      
-
       230,425      
-
  
$ 0.03       19,288       3.8       19,288       3.8  
  0.07       14,678,734       6.0       4,579,857       6.0  
  0.27       809,000       5.0       506,917       4.9  
  0.34       8,020       2.9       8,020       2.9  
  0.92       540,501       3.4       535,168       3.4  
  4.72       1,068       1.2       1,068       1.2  
  5.05       2,769       1.2       2,769       1.2  
$ 5.73       29,981       2.8       29,981       2.8  
          16,319,786               5,913,492          

 

      Outstanding     Exercisable  
Exercise price     Number of
options		     Weighted average remaining contractual life (years)     Number of
options		     Weighted average remaining contractual life (years)  
                           
 
(*
 )     230,425       3.4       230,425       3.4  
$ 0.03       19,597       5.8       19,597       5.8  
  0.27       809,000       8.6       291,125       8.4  
  0.34       8,020       3.9       8,020       3.9  
  0.45       63,097       0.7       63,097       0.7  
  0.92       650,424       6.2       563,382       6.0  
  4.72       1,068       2.2       1,068       2.2  
  5.05       2,769       2.2       2,769       2.2  
$ 5.73       29,981       3.8       29,981       3.8  
          1,814,381               1,209,464          

 
Schedule of stock based compensation
    Year Ended December 31,  
    2020     2019     2018  
                   
Research and Development   $ 167,328     $ 16,295     $ 36,723  
Sales and Marketing     48,671       7,209       14,837  
General and Administrative     248,774       86,109       102,430  
                         
    $ 464,773     $ 109,613     $ 153,990  

 
Schedule of outstanding warrants
Outstanding     Issuance
year		     Exercise
price		     Exercisable through      
                         
  117,209       2009     $ 
              (*
)     Exit event     (**)
  59,384       2013       0.92       2023     (**)
  170,000       2018       0.50       2023     Refer to Note 8.b.
  200,001       2018     $ 0.50       2023     Refer to Note 11.b.4.
                                 
  546,594                              

 

Outstanding     Issuance year   Exercise price     Exercisable through    
                     
  117,209     2009   $
(* )
     Exit event   (**)
  59,384     2013     0.92     2023   (**)
  600,000     2018     0.50     2023    
  170,000     2018     0.50     2023   Refer to Note 8.b.
  466,667     2018   $ 0.50     2023   Refer to Note 11.b.4.
                         
  1,413,260